Featured Research

from universities, journals, and other organizations

NIH Researchers Zero In On Viral Changes That Lead To Chronic Hepatitis C

Date:
April 14, 2000
Source:
National Institute Of Allergy And Infectious Diseases
Summary:
Scientists from the NIH and other institutions have discovered a clue that begins to explain why so many patients fail to fully recover from infection with the hepatitis C virus. Their research points to changes in surface proteins that enable the virus to evade the immune system. The study shows that the ultimate outcome of an HCV infection is determined during the initial, acute phase of disease.

Scientists from the National Institutes of Health (NIH) and other institutions have discovered a clue that begins to explain why so many patients fail to fully recover from infection with the hepatitis C virus (HCV). Their research, reported in the current issue of Science, points to changes in surface proteins that enable the virus to evade the immune system. The study shows that the ultimate outcome of an HCV infection is determined during the initial, acute phase of disease.

Related Articles


"Hepatitis C is a devastating disease that exacts a significant toll in this country and abroad, and whose full clinical impact has yet to be realized," states Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH. "This research helps to explain how the virus manages to persist in the body and provides physicians with a potential way to predict the development of a chronic infection."

Nearly 4 million Americans have been infected with the hepatitis C virus (HCV). Of those who contract hepatitis C, 85 percent remain chronically infected, harboring a virus that continues to replicate throughout a person's life. HCV is a major cause of chronic liver disease and is responsible for a third of all cases of cirrhosis and liver cancer, half of all liver transplants, and 8,000 to 10,000 deaths in this country annually.

Patrizia Farci, M.D., and Robert Purcell, M.D., of NIAID and Harvey Alter, M.D., of the NIH Warren Magnuson Clinical Center, led a team of scientists in a study designed to see whether the hepatitis C virus changes during infection. Dr. Alter had been conducting long-term studies of patients who contracted hepatitis from blood transfusions. These individuals subsequently developed different clinical outcomes, ranging from short-term infections to chronic disease. Some of these patients have had hepatitis C for over 20 years. "This unique group was critical for our study, because they had been observed continuously since early in infection," states Dr. Farci, who splits her time between NIAID in the United States and the University of Cagliari in Italy.

Three of the 12 patients studied had acute HCV infections, three had fulminant hepatitis (a rare but serious form of acute disease), and six had chronic hepatitis. The research team examined the virus in each person, looking specifically for changes in the genes that encode special proteins coating the viral surface. They also studied what changes occurred either before or after the body's immune system responded to HCV infection.

In some patients, the virus remained relatively unchanged following the initial immune response, and those people completely eliminated HCV over several weeks. In most, however, genetic HCV variants began to appear in response to the early immune assault. This rapid viral evolution ultimately resulted in chronic infection.

"We know that the body responds to infection early in the disease process, but in most patients the virus is 'smarter' than the immune system," states Dr. Farci. "In many cases, HCV changes its surface proteins as soon as the patient's antibodies begin to attack. In essence, the virus slips into a disguise and continues on without detection."

Similar masquerades are used by other viruses, such as HIV and influenza, but this is the first study to correlate such behavior with disease progression in hepatitis C. The researchers also determined a region on virus surface proteins where most of the changes occur. Their studies will now focus on the types of mutations that assist HCV in avoiding the immune system, and on the types of antibodies produced during the early response. By understanding more about this critical checkpoint in HCV infection, they hope to develop new tools for hepatitis C treatment and prevention.

Other collaborators from NIH, University of Cagliari, Kanazawa University (Japan), Chiron Corporation, and Albert Einstein Medical Center participated in this study.

NIAID is a component of the National Institutes of Health (NIH). NIAID conducts and supports research to prevent, diagnose and treat illness such as HIV disease and other sexually transmitted diseases, tuberculosis, malaria, asthma and allergies. NIH is an agency of the U.S. Department of Health and Human Services.

###

Reference:P Farci, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-44 (2000).

Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.


Story Source:

The above story is based on materials provided by National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Allergy And Infectious Diseases. "NIH Researchers Zero In On Viral Changes That Lead To Chronic Hepatitis C." ScienceDaily. ScienceDaily, 14 April 2000. <www.sciencedaily.com/releases/2000/04/000413145007.htm>.
National Institute Of Allergy And Infectious Diseases. (2000, April 14). NIH Researchers Zero In On Viral Changes That Lead To Chronic Hepatitis C. ScienceDaily. Retrieved April 25, 2015 from www.sciencedaily.com/releases/2000/04/000413145007.htm
National Institute Of Allergy And Infectious Diseases. "NIH Researchers Zero In On Viral Changes That Lead To Chronic Hepatitis C." ScienceDaily. www.sciencedaily.com/releases/2000/04/000413145007.htm (accessed April 25, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, April 25, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

85 Killed in Niger by Meningitis Since Start of Year

85 Killed in Niger by Meningitis Since Start of Year

AFP (Apr. 24, 2015) A meningitis outbreak in Niger has killed 85 people since the start of the year prompting authorities to close schools in the capital Niamey until Monday. Video provided by AFP
Powered by NewsLook.com
C-Section Births a Trend in Brazil

C-Section Births a Trend in Brazil

AFP (Apr. 24, 2015) More than half of Brazil&apos;s babies are born via cesarean section, as mothers and doctors opt for a faster and less painful experience despite the health risks. Duration: 02:02 Video provided by AFP
Powered by NewsLook.com
Anti-Malaria Jab Hope

Anti-Malaria Jab Hope

Reuters - News Video Online (Apr. 24, 2015) The world&apos;s first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
3D Food Printing: The Meal of the Future?

3D Food Printing: The Meal of the Future?

AP (Apr. 23, 2015) Developers of 3D food printing hope the culinary technology will revolutionize the way we cook and eat. (April 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins